VivoSeq
Other

Menopause

0

Pipeline Programs↗

17

Active Trials↗

10

Companies Involved↗

Menopause is an early-stage landscape with 0 programs across 10 companies. The most active players are Pfizer, Bayer, Novo Nordisk.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

34/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalNovo Nordisk logo

Novo Nordisk

0 programs

PreclinicalAstellas logo

Astellas

0 programs

PreclinicalSumitomo Pharma America, Inc. logo

Sumitomo Pharma America, Inc.

0 programs

PreclinicalN

Noema Pharma AG

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

68

clinical trials

Completed37 · 54%
Recruiting11 · 16%
Unknown status9 · 13%
Terminated4 · 6%
Not yet recruiting3 · 4%
Active, not recruiting3 · 4%
Other1 · 1%

Clinical Trials

Trial Activity

68 trials

Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
Recruiting·UUniversity of Sao Paulo General Hospital·Phase 3·NCT06343870·140 enrolled
Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause
Recruiting·UUniversity of Nove de Julho·N/A·NCT06873971·60 enrolled
Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause
Recruiting·KKanuni Sultan Suleyman Training and Research Hospital·N/A·NCT05571527·60 enrolled
COMPASS - COpenhagen MenoPAuSe Study
Recruiting·—·Phase 2·NCT07254429·192 enrolled
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
Recruiting·SStratpharma AG·N/A·NCT05672901·100 enrolled
Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms
Recruiting·UUniversity of Missouri-Columbia·Phase 1·NCT06787066·75 enrolled
No More Sleepless Nights in Perimenopause
Recruiting·IInsel Gruppe AG, University Hospital Bern·Phase 4·NCT06497894·54 enrolled
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
Recruiting·—·Phase 4·NCT07136415·1,000 enrolled
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Recruiting·WWashington State University·Phase 2·NCT07393672·104 enrolled
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
Recruiting·UUniversity of Missouri-Columbia·Phase 1·NCT06417177·75 enrolled
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
Recruiting·AAbCellera Biologics Inc.·Phase 1/2·NCT07118891·136 enrolled
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
Active, not recruiting·Astellas logoAstellas·Phase 3·NCT06206421·277 enrolled
LASER and Radiofrequency and Genitourinary Syndrome of Menopause
Active, not recruiting·FFederal University of São Paulo·N/A·NCT04045379·195 enrolled
Post-Menopause Skin Rejuvenation Study
Active, not recruiting·EErevna Innovations Inc.·Phase 4·NCT07205744·50 enrolled
Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause
Not yet recruiting·MMackay Memorial Hospital·N/A·NCT05483634·40 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)